Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide Maintenance Therapy in Extensive Stage SCLC
NCT02772107Phase 3Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in small cell lung cancer (SCLC), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
temozolomide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT02772107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02772107.